Atrium C-Qur Hernia Mesh Lawsuits
The FDA and independent medical studies have called into question the use of C-Qur hernia mesh. Infections, failed mesh, recurring hernias, and deaths in laboratory test animals have been reported in testing and real life use of the mesh. There was a 2013 recall for packaging issues.
Our firm has hernia, pelvic organ prolapse and stress urinary incontinence mesh litigation and settlement experience against multiple medical companies. If you or someone close to you has suffered due to the implantation of this mesh device, the experienced New York defective medical device attorneys at Rheingold Giuffra Ruffo & Plotkin LLP are here to stand up for your rights.
Helping Clients Nationwide
Contact us today online or by telephone at (888) 260-0473to speak with a knowledgeable New York product liability lawyer.
The C-Qur Hernia Patch Family of Products
Atrium is an international medical company which first sold C-Qur mesh products in 2006. The company was later bought by Maquet Getinge Group, a German Company. The mesh products include:
- Atrium C-Qur Mesh
- Atrium C-Qur Mosaic
- Atrium C-Qur TacShield
- Atrium C-Qur V-Patch
- Atrium C-Qur Centrifx
- Atrium C-Qur FX Mesh (formerly C-Qur Lite)
Problems Associated Hernia Mesh
- Infection near the time of surgery or months later. Infections can occur deep in the abdominal area or closer to the surface of the skin.
- Recurrence of the hernias due to mesh rejection, migration or failure
- Inflammation and chronic pain
- Internal scar tissue known as "adhesions" which result from foreign body reactions
C-Qur Mesh on the Radar of the FDA and Medical Researchers
In 2012, the FDA warned Atrium medical that the reports of mesh infection in patients were not being adequately addressed. In 2013, there was an FDA recall for Atrium mesh that was adhering to packaging. In 2015 there was an FDA injunction against the Atrium Hudson, New Hampshire manufacturing plant for failing to comply with safe manufacturing practices.
Leading medical and scientific journals who report studies on hernia mesh comparisons, which the medical community relies upon, have reported poor performance by C-Qur mesh. With respect to compared meshes, these studies showed more adhesions, less strength, infections and death in laboratory rats, a study halted for high infection rates, and failure of tissue ingrowth.
Preservation of removed mesh is an important step if considering litigation. Mesh is the property of the patient, and patients have the right to tell facilities to preserve the mesh or deliver the mesh to the patient's possession (or legal representative). Some doctors have patients sign a broad medical release which allows the doctor to return the mesh to the medical mesh manufacturer without notice to the patient.
Litigation Suited to your Personal Wishes
Many drug product liability cases evolve into three choices: participate in a settlement plan, mediation or litigating to a trial. The choice is yours and no one forces you into one option or another. Settlement plans often provide significant recoveries without the delays and expenses associated with trials.
At Rheingold Giuffra Ruffo & Plotkin LLP, our New York product liability lawyers help people who have been injured by faulty medical devices, including medical mesh. We advise clients about the merits of a potential claim, along with settlement and trial prospects.